• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

3
1
1
1

COUNTRY

1

CATEGORIES

  • 5
  • 4
  • 2
  • 2

PRICE

9
9
9
12

PUBLISHED

0
3
6
12

PRODUCT TYPE

8
3
1

Search "Salix Pharmaceuticals, Ltd.-Deals & Alliances Report" returned 12 results.

Salix Pharmaceuticals, Ltd. - Strategy and SWOT Report Salix Pharmaceuticals, Ltd. - Strategy and SWOT Report - Product Thumbnail Image

Salix Pharmaceuticals, Ltd. - Strategy and SWOT Report

Salix Pharmaceuticals, Ltd. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service...

September 2014
FROM

Salix Pharmaceuticals, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain...

May 2015
FROM

Salix Pharmaceuticals Ltd. (SLXP) - Financial and Strategic SWOT Analysis Review

Salix Pharmaceuticals Ltd. (SLXP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

April 2015
FROM
Salix Pharmaceuticals, Ltd. (SLXP) - Financial and Strategic SWOT Analysis Review Salix Pharmaceuticals, Ltd. (SLXP) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Salix Pharmaceuticals, Ltd. (SLXP) - Financial and Strategic SWOT Analysis Review

Salix Pharmaceuticals, Ltd. (SLXP) - Financial and Strategic SWOT Analysis Review Summary Salix Pharmaceuticals, Ltd. (Salix) is a specialty pharmaceutical company focusing on licensing, developing...

September 2011
FROM

Inflammatory Bowel Disease Therapeutics - Global Strategic Business Report

This report analyzes the Global market for Inflammatory Bowel Disease Therapeutics in US$ Million Annual estimates and forecasts are provided for the period 2006 through 2015 The report profiles 69...

April 2010
FROM
Cancer Diagnostics Partnering Terms and Agreements (3rd Edition) Cancer Diagnostics Partnering Terms and Agreements (3rd Edition) - Product Thumbnail Image

Cancer Diagnostics Partnering Terms and Agreements (3rd Edition)

The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies. ...

December 2014
FROM

Eisai Inc. - Strategic SWOT Analysis Review

Eisai Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis,...

July 2014
FROM

Prescription Drugs - Global Strategic Business Report

This report analyzes the worldwide markets for Prescription Drugs in US$ Billion by the following therapeutic class – Oncologics/ Cancer Drugs, Lipid Regulators, Respiratory Agents, Proton Pump Inhibitors,...

July 2009
FROM

Santarus, Inc. (SNTS) - Financial and Strategic SWOT Analysis Review

Summary Santarus, Inc. (Santarus) is a specialty biopharmaceutical company. It acquires, develops and commercializing pharmaceutical products. The company’s marketed products consists of Uceris (budesonide)...

March 2013
FROM
Pharmos Corporation (PARS) - Financial and Strategic SWOT Analysis Review Pharmos Corporation (PARS) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Pharmos Corporation (PARS) - Financial and Strategic SWOT Analysis Review

Pharmos Corporation (PARS) - Financial and Strategic SWOT Analysis Review Summary Pharmos Corporation (Pharmos) is a biopharmaceutical company, principally engaged in the discovery and development...

September 2011
FROM
Eisai Co., Ltd. - Product Pipeline Review - H2 2011 Eisai Co., Ltd. - Product Pipeline Review - H2 2011 - Product Thumbnail Image

Eisai Co., Ltd. - Product Pipeline Review - H2 2011

Eisai Co., Ltd. – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “Eisai Co., Ltd. - Product Pipeline Review - H2 2011” provides data on the Eisai Co., Ltd.’s...

November 2011
FROM
North American Corporate Rating Scores By Industry Sector As Of March 5, 2015 May 15 North American Corporate Rating Scores By Industry Sector As Of March 5, 2015 May 15 - Product Thumbnail Image

North American Corporate Rating Scores By Industry Sector As Of March 5, 2015 May 15

Abstract Standard & Poor's Ratings Services is updating the rating component scores for its public corporate credit ratings in North America. This article follows a similar report published on Feb....

May 2015
Loading Indicator

Our Clients

Amneal Pharmaceuticals LLC. Amgen Inc. LEO Laboratories Ltd. Pfizer, Inc. Roche Diagnostics Ltd. Merck & Co., Inc. Sanofi S.A.